Sanopaz 20 mg enterotabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sanopaz 20 mg enterotabletter

rivopharm limited - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg

Piptazira 2 g+0,25 g pulver til infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

piptazira 2 g+0,25 g pulver til infusionsvæske, opløsning

pfizer aps - piperacillinnatrium, tazobactamnatrium - pulver til infusionsvæske, opløsning - 2 g+0,25 g

Piptazira 4 g+0,5 g pulver til infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

piptazira 4 g+0,5 g pulver til infusionsvæske, opløsning

pfizer aps - piperacillinnatrium, tazobactamnatrium - pulver til infusionsvæske, opløsning - 4 g+0,5 g

Ronapreve Den Europæiske Union - dansk - EMA (European Medicines Agency)

ronapreve

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - immune sera og immunoglobuliner, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. se afsnit 4. 4 og 5.

Zynlonta Den Europæiske Union - dansk - EMA (European Medicines Agency)

zynlonta

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastiske midler - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.